Namely, the role of secondary mutations in epigenetically driven glioma has only been superficially defined,29 with an unclear role of key oncogenic driver genes such as EGFR, PTEN, RB1, NF1, TERT, and CDKN2A on modulating the tumor microenvironment. The gene discussed is CDKN2A; the disease is central nervous system cancer.